Position in VKTX
as of Jun 30, 2026
· filed Jul 1, 2026
Position Value
$773,100
+$127,084 QoQ
Shares Held
19,818
-0.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#1
of 14 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 1.6449692199011001.ToString("F0")%
Shared 0.ToString("F0")%
None 98.3550307800989.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PVG ASSET MANAGEMENT CORP holds $3,151,080 across 9 Biotechnology names. VKTX ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVXL |
Anavex Life Sciences Corp.
|
327,344 | $847,820 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
This page
|
19,818 | $773,100 | |
| 3 | IMRX |
Immuneering Corp
|
146,451 | $730,790 | |
| 4 | MDWD |
MediWound Ltd.
|
18,122 | $266,393 | |
| 5 | ALT |
Altimmune, Inc.
|
66,120 | $201,004 | |
| 6 | CHRS |
Coherus Oncology, Inc.
|
133,235 | $186,529 | |
| 7 | ARDX |
Ardelyx, Inc.
|
11,393 | $58,104 | |
| 8 | MAIA |
MAIA Biotechnology, Inc.
|
34,135 | $49,154 |
All Filings in VKTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $773,100 | 19,818 | Shares | Sole | 2026-07-01 | |
| 2026-03-31 | $646,016 | 19,853 | Shares | Sole | 2026-06-16 | |
| 2025-12-31 | $411,570 | 11,699 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $351,205 | 13,364 | Shares | Sole | 2025-12-31 | |
| 2025-06-30 | $298,337 | 11,258 | Shares | Sole | 2025-09-02 | |
| 2025-03-31 | $218,629 | 9,053 | Shares | Sole | 2025-06-04 | |
| 2022-09-30 | $40,283 | 14,810 | Shares | Sole | 2022-10-13 | |
| No filing history on record for this holder in this stock. | ||||||